Refractory IBS Patients React Well To Serum-Derived Bovine Immunoglobulin/Protein Isolate Therapy in Study

Refractory IBS Patients React Well To Serum-Derived Bovine Immunoglobulin/Protein Isolate Therapy in Study
Entera Health, Inc. announced the publication of a study entitled “Serum-Derived Bovine Immunoglobulin/Protein Isolate Therapy for Patients with Refractory Irritable Bowel Syndrome” that reports the positive results obtained after oral administration of serum-derived bovine immunoglobulin/protein isolate in patients with irritable bowel syndrome who were unresponsive to therapeutics (referred to as refractory). The study was published

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *